Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 706

1.

Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta.

Wranke A, Heidrich B, Ernst S, Calle Serrano B, Caruntu FA, Curescu MG, Yalcin K, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Bremer B, Stift J, Grabowski J, Kirschner J, Port K, Cornberg M, Falk CS, Dienes HP, Hardtke S, Manns MP, Yurdaydin C, Wedemeyer H; HIDIT-2 Study Group.

PLoS One. 2014 Jul 29;9(7):e101002. doi: 10.1371/journal.pone.0101002. eCollection 2014.

PMID:
25072849
[PubMed - in process]
2.

A Randomized Phase 2b Study of Peginterferon Lambda-1a for the Treatment of Chronic HCV Infection.

Muir AJ, Arora S, Everson G, Flisiak R, George J, Ghalib R, Gordon SC, Gray T, Greenbloom S, Hassanein T, Hillson J, Horga MA, Jacobson IM, Jeffers L, Kowdley KV, Lawitz E, Lueth S, Rodriguez-Torres M, Rustgi V, Shemanski L, Shiffman ML, Srinivasan S, Vargas HE, Vierling JM, Xu D, Lopez-Talavera JC, Zeuzem S; for the EMERGE study group.

J Hepatol. 2014 Jul 23. pii: S0168-8278(14)00521-2. doi: 10.1016/j.jhep.2014.07.022. [Epub ahead of print]

PMID:
25064437
[PubMed - as supplied by publisher]
3.

Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis - a prospective cohort study.

Pleli T, Martin D, Kronenberger B, Brunner F, Köberle V, Grammatikos G, Farnik H, Martinez Y, Finkelmeier F, Labocha S, Ferreirós N, Zeuzem S, Piiper A, Waidmann O.

PLoS One. 2014 Jul 25;9(7):e103532. doi: 10.1371/journal.pone.0103532. eCollection 2014.

PMID:
25062038
[PubMed - in process]
Free PMC Article
4.

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate.

Marcellin P, Buti M, Krastev Z, de Man RA, Zeuzem S, Lou L, Gaggar A, Flaherty JF, Massetto B, Lin L, Dinh P, Mani Subramanian G, McHutchison JG, Flisiak R, Gurel S, Dusheiko GM, Jenny Heathcote E.

J Hepatol. 2014 Jul 18. pii: S0168-8278(14)00518-2. doi: 10.1016/j.jhep.2014.07.019. [Epub ahead of print]

PMID:
25046847
[PubMed - as supplied by publisher]
5.

Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late.

Pellicelli AM, Montalbano M, Lionetti R, Durand C, Ferenci P, D'Offizi G, Knop V, Telese A, Lenci I, Andreoli A, Zeuzem S, Angelico M.

Dig Liver Dis. 2014 Jul 2. pii: S1590-8658(14)00400-9. doi: 10.1016/j.dld.2014.06.004. [Epub ahead of print]

PMID:
24997638
[PubMed - as supplied by publisher]
6.

[In Process Citation].

Hézode C, Brainard D, Pol S, Libert O, Symondq W, McHutchison J, Zeuzem S.

Med Mal Infect. 2014 Jun;44(6 Suppl):1. doi: 10.1016/S0399-077X(14)70040-X. French. No abstract available.

PMID:
24994127
[PubMed - in process]
7.

Multi-center proficiency tests for Lab-MELD score diagnostics to improve the quality and safety for patients awaiting liver transplantation.

Kaiser T, Zeuzem S, Lichtinghagen R, Welker MW, Geilenkeuser WJ, Kruse R, Neumaier M, Thiery J, Schmidt M.

Clin Chem Lab Med. 2014 Jun 24. pii: /j/cclm.ahead-of-print/cclm-2014-0088/cclm-2014-0088.xml. doi: 10.1515/cclm-2014-0088. [Epub ahead of print] No abstract available.

PMID:
24960153
[PubMed - as supplied by publisher]
8.

Feasibility of global microRNA analysis from fine-needle biopsy FFPE material in patients with hepatocellular carcinoma treated with sorafenib.

Peveling-Oberhag J, Döring C, Hartmann S, Filmann N, Mertens A, Piiper A, Herrmann E, Hansmann ML, Zeuzem S, Trojan J, Welker MW.

Clin Sci (Lond). 2014 Jun 24. [Epub ahead of print]

PMID:
24959956
[PubMed - as supplied by publisher]
9.

Development and Validation of a Prognostic Score to Predict Mortality in Patients with Acute on Chronic Liver Failure.

Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, Hopf C, Alessandria C, Rodriguez E, Solis-Muñoz P, Laleman W, Trebicka J, Zeuzem S, Gustot T, Mookerjee R, Elkrief L, Soriano G, Cordoba J, Morando F, Gerbes A, Agarwal B, Samuel D, Bernardi M, Arroyo V; for the CANONIC study investigators of the EASL-CLIF Consortium.

J Hepatol. 2014 Jun 17. pii: S0168-8278(14)00408-5. doi: 10.1016/j.jhep.2014.06.012. [Epub ahead of print]

PMID:
24950482
[PubMed - as supplied by publisher]
10.

The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis.

Grammatikos G, Farnik H, Bon D, Böhlig A, Bader T, Berg T, Zeuzem S, Herrmann E.

J Viral Hepat. 2014 Aug;21(8):533-41. doi: 10.1111/jvh.12274. Epub 2014 Jun 18.

PMID:
24943517
[PubMed - in process]
11.

Rejection quantity in kidney transplant recipients is associated with increasing intracellular interleukin-2 in CD8+ T-cells.

Akoglu B, Lafferton B, Kalb S, Yosuf SE, Herrmann E, Zeuzem S, Goßmann J, Kachel HG, Scheuermann EH, Faust D.

Transpl Immunol. 2014 Jun;31(1):17-21. doi: 10.1016/j.trim.2014.05.004. Epub 2014 Jun 2.

PMID:
24887424
[PubMed - in process]
12.

The capsule endoscopy "suspected blood indicator" (SBI) for detection of active small bowel bleeding: no active bleeding in case of negative SBI.

Tal AO, Filmann N, Makhlin K, Hausmann J, Friedrich-Rust M, Herrmann E, Zeuzem S, Albert JG.

Scand J Gastroenterol. 2014 Jun 2:1-5. [Epub ahead of print]

PMID:
24884306
[PubMed - as supplied by publisher]
13.

Commentary: vitamin D deficiency and liver cancer - cause, effect or myth? Authors' reply.

Finkelmeier F, Kronenberger B, Köberle V, Bojunga J, Zeuzem S, Trojan J, Piiper A, Waidmann O.

Aliment Pharmacol Ther. 2014 Jun;39(12):1429-30. doi: 10.1111/apt.12772. No abstract available.

PMID:
24849152
[PubMed - in process]
14.

Molecular Mechanism of Regulation of the Atypical Protein Kinase C by N-terminal Domains and an Allosteric Small Compound.

Zhang H, Neimanis S, Lopez-Garcia LA, Arencibia JM, Amon S, Stroba A, Zeuzem S, Proschak E, Stark H, Bauer AF, Busschots K, Jørgensen TJ, Engel M, Schulze JO, Biondi RM.

Chem Biol. 2014 Jun 19;21(6):754-65. doi: 10.1016/j.chembiol.2014.04.007. Epub 2014 May 15.

PMID:
24836908
[PubMed - in process]
15.

Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters.

van der Meer AJ, Hansen BE, Fattovich G, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, Duarte-Rojo A, Manns MP, Ieluzzi D, Zeuzem S, Hofmann WP, de Knegt RJ, Veldt BJ, Janssen HL.

Gut. 2014 May 9. doi: 10.1136/gutjnl-2013-305357. [Epub ahead of print]

PMID:
24815676
[PubMed - as supplied by publisher]
16.

Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR study.

Gane EJ, Pockros PJ, Zeuzem S, Marcellin P, Shikhman A, Bernaards C, Zhou J, Yetzer ES, Ballester R, Dwyer C, Tong X, Nájera I, Bertasso A, Hammond J, Kindrick A, Morcos PN, Smith P, Stancic S, Shulman NS.

Liver Int. 2014 May 10. doi: 10.1111/liv.12588. [Epub ahead of print]

PMID:
24814388
[PubMed - as supplied by publisher]
17.

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

Zeuzem S, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH, Illeperuma A, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Weiland O, Reesink HW, Ferenci P, Hézode C, Esteban R; VALENCE Investigators.

N Engl J Med. 2014 May 22;370(21):1993-2001. doi: 10.1056/NEJMoa1316145. Epub 2014 May 4.

PMID:
24795201
[PubMed - indexed for MEDLINE]
18.

Interferon-free strategies without a nucleoside/nucleotide analogue.

Welzel TM, Zeuzem S.

Semin Liver Dis. 2014 Feb;34(1):47-57. doi: 10.1055/s-0034-1371010. Epub 2014 Apr 29. Erratum in: Semin Liver Dis. 2014 May;34(2):252.

PMID:
24782258
[PubMed - in process]
19.

Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis.

Maan R, van der Meer AJ, Hansen BE, Feld JJ, Wedemeyer H, Dufour JF, Zangneh HF, Lammert F, Manns MP, Zeuzem S, Janssen HL, de Knegt RJ, Veldt BJ.

J Hepatol. 2014 Apr 26. pii: S0168-8278(14)00284-0. doi: 10.1016/j.jhep.2014.04.021. [Epub ahead of print]

PMID:
24780302
[PubMed - as supplied by publisher]
20.

Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease.

Grammatikos G, Mühle C, Ferreiros N, Schroeter S, Bogdanou D, Schwalm S, Hintereder G, Kornhuber J, Zeuzem S, Sarrazin C, Pfeilschifter J.

Biochim Biophys Acta. 2014 Jul;1841(7):1012-20. doi: 10.1016/j.bbalip.2014.04.007. Epub 2014 Apr 25.

PMID:
24769340
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk